TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
active
Official procurement procedure

The Supply, Delivery, Installation and Maintenance of General Laboratory Equipment (Multiple Items)

Laboratory
optical and precision equipments (excl. glasses)
Published value
£280,000
Submission deadline 13 Dec 2021, 12:00 GMT
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Medicines Discovery Catapult: "The Supply, Delivery, Installation and Maintenance of General Laboratory Equipment (Multiple Items)". Published status: active. Published value: £280,000. 1 published lot. Recorded submission deadline: 13 Dec 2021, 12:00 GMT. See the official notice for participation instructions.
Contracting AuthorityMedicines Discovery CatapultScope & CategoriesNot publishedSubmission Window
Closed
13 Dec 2021, 12:00 GMT
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)£280,000
Bidder Intelligence · Authority Profile: Medicines Discovery Catapult
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for Medicines Discovery Catapult. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
1.3Bids / Report
66.7% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 4 active published awards; 3 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityMedicines Discovery Catapult
Procedure methodNot published
Procurement categoryNot published
Statusactive
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published11 Nov 2021, 12:18 GMT
Last source update11 Nov 2021, 12:18 GMT
Recurring procurementNo
ClassificationLaboratory, optical and precision equipments (excl. glasses)
Delivery area
OCIDocds-h6vhtk-02f5b1
What is being bought
Medicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change. MDC wishes to create a new CL3 facility for innovative diagnostics, biomarkers and complex medicines and develop the UK’s onshore diagnostic capability and capacity and the associated supply chain. The project will create a national facility for testing and validation of new diagnostics, biomarkers and innovative therapeutics for disease. The Validation Centre of Excellence will enable innovators to set up new companies with confidence, driving regional growth in high-value jobs and a sector of urgent national and global need. The Centre will build on the Lighthouse brand, creating a hub for new diagnostic and therapeutic validation. This tender is for General Laboratory Equipment (Multiple Items), which will be used in the new facility. Further information can be found at https://procontract.due-north.com/RFx/RFxSummary?rfxId=5e401949-e842-ec11-810e-005056b64545
What changed
From the official release history
  1. Published value updated to £280,000
    11 Nov 2021, 12:18 GMT
  2. Status changed to active
    11 Nov 2021, 12:18 GMT
  3. Official notice release published
    11 Nov 2021, 12:18 GMT
  4. Submission deadline changed to 13 Dec 2021, 12:00 GMT
    11 Nov 2021, 12:18 GMT
  5. Buyer information updated
    11 Nov 2021, 12:18 GMT
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    active
    Published valueNot published
    Medicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change. MDC wishes to create a new CL3 facility for innovative diagnostics, biomarkers and complex medicines and develop the UK’s onshore diagnostic capability and capacity and the associated supply chain. The project will create a national facility for testing and validation of new diagnostics, biomarkers and innovative therapeutics for disease. The Validation Centre of Excellence will enable innovators to set up new companies with confidence, driving regional growth in high-value jobs and a sector of urgent national and global need. The Centre will build on the Lighthouse brand, creating a hub for new diagnostic and therapeutic validation. This tender is for General Laboratory Equipment (Multiple Items), which will be used in the new facility. An open procurement procedure is being used. Further information can be found at https://procontract.due-north.com/RFx/RFxSummary?rfxId=5e401949-e842-ec11-810e-005056b64545
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    11 Nov 2021, 12:18 GMT
  2. Submission deadline
    13 Dec 2021, 12:00 GMT
Commercial outcome and competition
AwardsNo award published
ContractsNo contract published
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

Medicines Discovery Catapult

Contracting authority GB-FTS-23690
View buyer profile
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published